Biotech Values

[microcapfun]

ONXX

>>Why is the sales uptake so much slower in the US than in Europe?<<

As pgs indicated, liver cancer is a relatively rare indication inside the U.S. but is much more prevalent in Europe and Asia.

Nexavar is approved in kidney and liver cancer, but is losing ground in the former while still ramping up in the latter (where there is no other approved systemic therapy).

micro